- Home
- PBM vs PSTV Comparison
PBM vs PSTV Comparison
Compare PBM & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBM
- PSTV
- Stock Information
- Founded
- PBM 1994
- PSTV 1996
- Country
- PBM Canada
- PSTV United States
- Employees
- PBM N/A
- PSTV N/A
- Industry
- PBM
- PSTV Medical/Dental Instruments
- Sector
- PBM
- PSTV Health Care
- Exchange
- PBM NYSE
- PSTV Nasdaq
- Market Cap
- PBM 7.5M
- PSTV 6.3M
- IPO Year
- PBM N/A
- PSTV N/A
- Fundamental
- Price
- PBM $1.79
- PSTV $1.17
- Analyst Decision
- PBM
- PSTV Strong Buy
- Analyst Count
- PBM 0
- PSTV 2
- Target Price
- PBM N/A
- PSTV $13.50
- AVG Volume (30 Days)
- PBM 5.4M
- PSTV 38.1K
- Earning Date
- PBM 02-02-2025
- PSTV 03-04-2025
- Dividend Yield
- PBM N/A
- PSTV N/A
- EPS Growth
- PBM N/A
- PSTV N/A
- EPS
- PBM N/A
- PSTV N/A
- Revenue
- PBM N/A
- PSTV $5,725,000.00
- Revenue This Year
- PBM N/A
- PSTV $32.12
- Revenue Next Year
- PBM N/A
- PSTV N/A
- P/E Ratio
- PBM N/A
- PSTV N/A
- Revenue Growth
- PBM N/A
- PSTV 52.63
- 52 Week Low
- PBM $1.51
- PSTV $0.93
- 52 Week High
- PBM $593.25
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- PBM 39.22
- PSTV 47.54
- Support Level
- PBM $1.61
- PSTV $1.12
- Resistance Level
- PBM $2.25
- PSTV $1.24
- Average True Range (ATR)
- PBM 0.22
- PSTV 0.08
- MACD
- PBM 0.06
- PSTV 0.01
- Stochastic Oscillator
- PBM 23.38
- PSTV 30.77
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).